BioNxt Solutions Inc. (CVE:BNXT)

PRESS RELEASE

published on 09/20/2025 at 01:30, 4 months 15 days ago

Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals
BioNxt Solutions Inc. announces Terry Lynch as capital markets advisor and retention of two investor relations professionals, Rob Grace and Blaine Ruzcki, for promotional activities. Company focuses on bioscience innovations with drug delivery platforms

BioNxt Solutions Inc. Terry Lynch Investor Relations Professionals Bioscience Innovations Drug Delivery Platforms
BRIEF

published on 09/15/2025 at 09:10, 4 months 20 days ago

BioNxt Progresses with Semaglutide Oral Film Program

Patent Filing Prototype Development BioNxt Semaglutide ODF GLP-1 Market
BRIEF

published on 09/15/2025 at 09:10, 4 months 20 days ago

BioNxt progresse avec son programme de films oraux à base de sémaglutide

Dépôt De Brevet Développement De Prototypes BioNxt Semaglutide ODF Marché Du GLP-1
PRESS RELEASE

published on 09/15/2025 at 09:05, 4 months 20 days ago

BioNxt Advances Semaglutide Oral Dissolvable Film (ODF) Program with Successful Proof-of-Concept and Prototype Development
BioNxt achieves successful proof-of-concept trials for Semaglutide oral dissolvable film program, advancing to next development phase in GLP-1 market for diabetes and obesity therapies

Drug Delivery Semaglutide BioNxt GLP-1 Market Proof-of-concept
BRIEF

published on 09/13/2025 at 01:05, 4 months 22 days ago

BioNxt Settles Debt with Share and Cash Agreement

Debt Settlement Canadian Securities Exchange Regulatory Approvals BioNxt Solutions Share Agreement
BRIEF

published on 09/13/2025 at 01:05, 4 months 22 days ago

BioNxt règle sa dette grâce à un accord en actions et en espèces

Bourse Des Valeurs Canadiennes Approbations Réglementaires Règlement De La Dette Solutions BioNxt Accord De Partage
PRESS RELEASE

published on 09/13/2025 at 01:00, 4 months 22 days ago

BioNxt Announces Shares for Debt Settlement
BioNxt Solutions Inc. announces a debt settlement agreement with a creditor, issuing common shares and making a cash payment. Company focuses on bioscience innovations and drug delivery technologies

Innovation Debt Settlement BioScience Drug Delivery BioNxt
BRIEF

published on 09/05/2025 at 09:10, 5 months ago

BioNxt Solutions fait ses débuts sur le marché OTCQB

Divulgation Financière Marché OTCQB Développement De Médicaments Investisseurs Américains Solutions BioNxt
BRIEF

published on 09/05/2025 at 09:10, 5 months ago

BioNxt Solutions Debuts on OTCQB Market

Financial Disclosure Drug Development US Investors BioNxt Solutions OTCQB Market
PRESS RELEASE

published on 09/05/2025 at 09:05, 5 months ago

BioNxt Solutions Completes Up-Listing to The OTCQB Market
BioNxt Solutions Inc. announces up-listing to OTCQB market, expanding access to US investors. Three drug development programs underway in Europe & North America. Company focuses on innovative drug delivery platforms

Drug Development BioNxt Solutions Inc. US Investors OTCQB Market Innovative Drug Delivery

Published on 02/05/2026 at 16:40, 25 minutes ago

Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 1 hour 20 minutes ago

American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 1 hour 55 minutes ago

Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 2 hours 15 minutes ago

High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 14:30, 2 hours 35 minutes ago

Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call

View all ACCESSWIRE

Published on 02/05/2026 at 16:30, 35 minutes ago

Dividend Declaration
Published on 02/05/2026 at 16:20, 44 minutes ago

Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy
Published on 02/05/2026 at 16:20, 44 minutes ago

Birla Carbon Launches New Continua™ SCM Production Line in Italy
Published on 02/05/2026 at 15:56, 1 hour 8 minutes ago

Original-Research: Verve Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 02/05/2026 at 15:40, 1 hour 25 minutes ago

BIKE24 exceeds revenue and earnings forecast for fiscal year 2025 – strong growth in the fourth quarter

View all EQS

Published on 02/05/2026 at 16:35, 29 minutes ago

Voting rights
Published on 02/05/2026 at 16:35, 29 minutes ago

Droits de vote
Published on 02/05/2026 at 16:04, 1 hour 1 minute ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 02/05/2026 at 16:02, 1 hour 2 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Published on 02/05/2026 at 11:30, 5 hours 35 minutes ago

Déclaration nombre d'actions et droits de vote - 05.02.2026

View all LES ECHOS COMFI WIRE

News